Amerigo Announces Q1-2024 Results & Quarterly Dividend
GlobeNewswire
*Q1-2024 net income of $4.3 million**Quarterly EBITDA*^*1 **of $13.6 million – free cash flow to equity*^*1** of $7.3..
*Q1-2024 net income of $4.3 million**Quarterly EBITDA*^*1 **of $13.6 million – free cash flow to equity*^*1** of $7.3..
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024" report has..
*THE GROUP CONTINUES TO GROW*
*CASA AND CAG STATED AND UNDERLYING DATA..